SCHEMBL17891381

SCHEMBL17891381

CCN(c1cc(Cl)cc(C(=O)NCc2c(C)[nH]n(CC)c2=O)c1C)C1CCC(N(C)C)CC1

nearest known ligand 0.73

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ EZH2 Q15910 20/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16398077 1.00 EZH2 (0.73) EZH2
SCHEMBL16398356 0.91 EZH2 (0.77) EZH2
SCHEMBL16402586 0.91 EZH2 (0.77) EZH2
SCHEMBL16402668 0.88 EZH2 (0.71) EZH2
SCHEMBL16402666 0.88 EZH2 (0.71) EZH2
SCHEMBL16402549 0.88 EZH2 (0.71) EZH2
SCHEMBL16402552 0.88 EZH2 (0.71) EZH2
SCHEMBL16408153 0.85 EZH2 (0.73) EZH2
SCHEMBL14703520 0.84 EZH2 (1.00) EZH2
SCHEMBL15710511 0.84 EZH2 (1.00) EZH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10150764-B2 Substituted benzene compounds Epizyme, Inc. (US) 2018-12-11 — — US disclosed
EP-3022184-B1 SUBSTITUTED BENZENE COMPOUNDS EPIZYME INC (US) 2017-09-27 — — EP disclosed
US-20160194316-A1 SUBSTITUTED BENZENE COMPOUNDS Epizyme, Inc. 2016-07-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160194316-A1 SUBSTITUTED BENZENE COMPOUNDS CYP1B1, TP53, VHL EZH2 2519/4885
US-10150764-B2 Substituted benzene compounds CYP1B1, TP53, VHL EZH2 2519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback